Quang X. Pham, CEO and Chairman at Cadrenal Therapeutics, Inc. (CVKD), sold 16,161 shares at $14.09 ($227K) on 2025-09-25, disclosed to the SEC on 2025-09-26.
Scheduled sale ($227k) by CEO and Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.99 | 2,581 | $36K | 15.9% |
| 2 | $14.09 | 6,790 | $96K | 42.1% |
| 3 | $14.09 | 6,790 | $96K | 42.1% |
| Total | $14.07 avg | 16,161 | $227K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |